GLP-1 Agonists: Wonder Drugs of the 21st Century?


The first drug in a class known as GLP-1 agonists was approved in 2005 to treat diabetes. GLP-1 drugs subsequently proved their mettle to treat obesity and prevent major cardiovascular events and will likely soon be available to treat sleep apnea as well. Looking ahead, their action on the brain is prompting research to gauge their value in curbing drug, alcohol, and nicotine cravings. But these seeming miracle drugs are costly, not always covered by insurance, and generally need to be taken forever. How do they work, what else might they do, and how do we ensure they are accessible to those who need them most?

  • 2024 Health

Explore More


125 ideas
Sorry, we couldn't find any results
Clear filters

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
aerial 2019 campus
Sign up to receive the latest news from Aspen Ideas.